Ads
related to: Copd Treatments
Search results
Finding Undiagnosed Asthma, COPD and Treating It Shows Benefit in Trial
MedPage Today· 6 days agoIdentifying symptomatic individuals in the community with undiagnosed asthma and chronic obstructive...
World-first trial shows benefits of finding and treating undiagnosed asthma and COPD
Medical Xpress· 7 days ago"It's estimated that 70% of people with asthma or COPD go undiagnosed," said study lead Dr. Shawn Aaron, a senior scientist and lung specialist at The Ottawa Hospital and ...
Asthma, COPD often not diagnosed, study indicates
UPI· 7 days agoFinding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease improved their health and led to fewer appointments for...
...® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and...
Benzinga· 6 days agoNOTUS results confirm landmark data from the Phase 3 BOREAS trial and show Dupixent significantly reduced exacerbations by 34% and improved lung function, compared to placebo, in uncontrolled chronic obstructive
Lung Cancer Screening IDs Pulmonary Comorbidities
Medscape· 3 days agoA majority of individuals with no reported history of COPD showed evidence of COPD symptoms.
Add-On Dupilumab for COPD Backed by Second Phase III Trial
MedPage Today· 5 days agoAdding dupilumab (Dupixent) to triple therapy reduced exacerbations and improved lung function for...
Tezepelumab Shows Potential for COPD, Negative Trial Notwithstanding
MedPage Today· 4 days agoAsthma drug may benefit patients with blood eosinophil counts indicative of type 2 inflammation
Study finds eliminating race-based metrics improves prediction for COPD outcomes
Medical Xpress· 5 days agoResults are published in the American Journal of Respiratory and Critical Care Medicine. COPD is a...
Up to 70% of People With Asthma and COPD Go Undiagnosed
The New York Times via Yahoo News· 5 days agoIn spring 2020, Jazzminn Hein received an automated phone call from The Ottawa Hospital in Canada,...
2 Biotech Stocks to Buy in May
Motley Fool via Yahoo Finance· 23 hours agoThe drug's global sales in the first quarter (recorded by Sanofi) came in at $3.1 billion, up 24% year over year. Dupixent is currently racing toward an...
